spacer
spacer

PDBsum entry 1wdy

Go to PDB code: 
protein ligands links
Hydrolase PDB id
1wdy

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
285 a.a. *
Ligands
25A
Waters ×220
* Residue conservation analysis
PDB id:
1wdy
Name: Hydrolase
Title: Crystal structure of ribonuclease
Structure: 2-5a-dependent ribonuclease. Chain: a. Fragment: residues 21-305. Synonym: 2-5a-dependent rnase, ribonuclease l, rnase l, ribonuclease 4. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
1.80Å     R-factor:   0.203     R-free:   0.230
Authors: N.Tanaka,M.Nakanishi,Y.Kusakabe,Y.Goto,Y.Kitade,K.T.Nakamura
Key ref:
N.Tanaka et al. (2004). Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L. EMBO J, 23, 3929-3938. PubMed id: 15385955 DOI: 10.1038/sj.emboj.7600420
Date:
19-May-04     Release date:   05-Oct-04    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
Q05823  (RN5A_HUMAN) -  2-5A-dependent ribonuclease from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
741 a.a.
285 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 1 residue position (black cross)

 Enzyme reactions 
   Enzyme class: E.C.3.1.26.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1038/sj.emboj.7600420 EMBO J 23:3929-3938 (2004)
PubMed id: 15385955  
 
 
Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
N.Tanaka, M.Nakanishi, Y.Kusakabe, Y.Goto, Y.Kitade, K.T.Nakamura.
 
  ABSTRACT  
 
An interferon-induced endoribonuclease, ribonuclease L (RNase L), is implicated in both the molecular mechanism of action of interferon and the fundamental control of RNA stability in mammalian cells. RNase L is catalytically active only after binding to an unusual activator molecule containing a 5'-phosphorylated 2',5'-linked oligoadenylate (2-5A), in the N-terminal half. Here, we report the crystal structure of the N-terminal ankyrin repeat domain (ANK) of human RNase L complexed with the activator 2-5A. This is the first structural view of an ankyrin repeat structure directly interacting with a nucleic acid, rather than with a protein. The ANK domain folds into eight ankyrin repeat elements and forms an extended curved structure with a concave surface. The 2-5A molecule is accommodated at a concave site and directly interacts with ankyrin repeats 2-4. Interestingly, two structurally equivalent 2-5A binding motifs are found at repeats 2 and 4. The structural basis for 2-5A recognition by ANK is essential for designing stable 2-5As with a high likelihood of activating RNase L.
 
  Selected figure(s)  
 
Figure 1.
Figure 1 Crystal structure of ANK complexed with 2-5A. (A) Structural and functional domains of RNase L. Ankyrin repeats are shown starting with blue at repeat 1 and ending with red at repeat 8. (B) Structure of the predominant trimeric species of 2-5A ((pp)p(A2'p5')[2]A) (Kerr and Brown, 1978). (C, D) Surface (top) and ribbon (bottom) representations of the ANK/2-5A complex. Ankyrin repeats (R1 -R8) are shown as in (A). The bound 2-5A molecule is shown as a ball-and-stick model. The view in (D) was obtained by rotating the view in (C) by 90°.
Figure 3.
Figure 3 Recognition of 2-5A by ANK. (A) Stereodiagram showing the mode of 2-5A binding to ANK. The carbon atoms of ANK are colored as in Figure 1, and those of the bound 2-5A molecule are shown in white. Possible hydrogen bonds or salt bridges are indicated by dashed lines, and distances (in Å) are given. The refined model is superimposed on the weighted 2|F[o]| -|F[c]| map (1.5 , yellow) and the |F[o]| -|F[c]| omit map of 2-5A (4.5 , orange), calculated at 1.8 Å resolution. Bound water molecules are shown as spheres (cyan). (B, C) Recognition of the first and third AMP moieties of 2-5A by repeats 4 and 2, respectively, of ANK.
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: EMBO J (2004, 23, 3929-3938) copyright 2004.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
22157957 J.D.Licchesi, J.Mieszczanek, T.E.Mevissen, T.J.Rutherford, M.Akutsu, S.Virdee, F.El Oualid, J.W.Chin, H.Ovaa, M.Bienz, and D.Komander (2012).
An ankyrin-repeat ubiquitin-binding domain determines TRABID's specificity for atypical ubiquitin chains.
  Nat Struct Mol Biol, 19, 62-71.
PDB code: 3zrh
21190483 A.Chakrabarti, B.K.Jha, and R.H.Silverman (2011).
New insights into the role of RNase L in innate immunity.
  J Interferon Cytokine Res, 31, 49-57.  
21229141 T.Shiraishi, Y.Kitamura, Y.Ueno, and Y.Kitade (2011).
Synthesis of oligonucleotides possessing versatile probes for PET labelling and their rapid ligand-free click reaction.
  Chem Commun (Camb), 47, 2691-2693.  
20154666 J.A.Zorn, and J.A.Wells (2010).
Turning enzymes ON with small molecules.
  Nat Chem Biol, 6, 179-188.  
19968858 W.M.Li, T.Barnes, and C.H.Lee (2010).
Endoribonucleases--enzymes gaining spotlight in mRNA metabolism.
  FEBS J, 277, 627-641.  
18575592 B.E.Madsen, E.M.Ramos, M.Boulard, K.Duda, J.Overgaard, M.Nordsmark, C.Wiuf, and L.L.Hansen (2008).
Germline mutation in RNASEL predicts increased risk of head and neck, uterine cervix and breast cancer.
  PLoS ONE, 3, e2492.  
18426919 H.L.Townsend, B.K.Jha, J.Q.Han, N.K.Maluf, R.H.Silverman, and D.J.Barton (2008).
A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.
  RNA, 14, 1026-1036.  
18414734 R.Gaudet (2008).
A primer on ankyrin repeat function in TRP channels and beyond.
  Mol Biosyst, 4, 372-379.  
17603100 A.Wagner (2007).
Rapid detection of positive selection in genes and genomes through variation clusters.
  Genetics, 176, 2451-2463.  
17400356 C.Bisbal, and R.H.Silverman (2007).
Diverse functions of RNase L and implications in pathology.
  Biochimie, 89, 789-798.  
17604869 C.L.Washenberger, J.Q.Han, K.J.Kechris, B.K.Jha, R.H.Silverman, and D.J.Barton (2007).
Hepatitis C virus RNA: dinucleotide frequencies and cleavage by RNase L.
  Virus Res, 130, 85-95.  
17535916 C.S.Thakur, B.K.Jha, B.Dong, J.Das Gupta, K.M.Silverman, H.Mao, H.Sawai, A.O.Nakamura, A.K.Banerjee, A.Gudkov, and R.H.Silverman (2007).
Small-molecule activators of RNase L with broad-spectrum antiviral activity.
  Proc Natl Acad Sci U S A, 104, 9585-9590.  
17822564 J.J.Rios, A.A.Perelygin, M.T.Long, T.L.Lear, A.A.Zharkikh, M.A.Brinton, and D.L.Adelson (2007).
Characterization of the equine 2'-5' oligoadenylate synthetase 1 (OAS1) and ribonuclease L (RNASEL) innate immunity genes.
  BMC Genomics, 8, 313.  
17344297 J.Q.Han, H.L.Townsend, B.K.Jha, J.M.Paranjape, R.H.Silverman, and D.J.Barton (2007).
A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L.
  J Virol, 81, 5561-5572.  
17910011 K.Morita, M.Kaneko, S.Obika, T.Imanishi, Y.Kitade, and M.Koizumi (2007).
Biologically Stable 2-5A Analogues containing 3'-O,4'-C-bridged Adenosine as Potent RNase L Agonists.
  ChemMedChem, 2, 1703-1707.  
17917424 N.Tanaka (2007).
[Structural and functional studies on proteins as potential drug discovery targets]
  Yakugaku Zasshi, 127, 1673-1683.  
17804500 R.H.Silverman (2007).
Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.
  J Virol, 81, 12720-12729.  
17681844 R.H.Silverman (2007).
A scientific journey through the 2-5A/RNase L system.
  Cytokine Growth Factor Rev, 18, 381-388.  
17869375 S.Chevaliez, and J.M.Pawlotsky (2007).
Interferon-based therapy of hepatitis C.
  Adv Drug Deliv Rev, 59, 1222-1241.  
17115900 H.Rennert, C.Sadowl, J.Edwards, D.Bantly, R.J.Molinaro, A.Orr-Urtreger, A.Bagg, J.S.Moore, and R.H.Silverman (2006).
An alternative spliced RNASEL variant in peripheral blood leukocytes.
  J Interferon Cytokine Res, 26, 820-826.  
16241858 A.Zhou, R.J.Molinaro, K.Malathi, and R.H.Silverman (2005).
Mapping of the human RNASEL promoter and expression in cancer and normal cells.
  J Interferon Cytokine Res, 25, 595-603.  
16234235 M.Nakanishi, N.Tanaka, Y.Mizutani, M.Mochizuki, Y.Ueno, K.T.Nakamura, and Y.Kitade (2005).
Functional characterization of 2',5'-linked oligoadenylate binding determinant of human RNase L.
  J Biol Chem, 280, 41694-41699.  
15849753 M.Nakanishi, Y.Goto, and Y.Kitade (2005).
2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
  Proteins, 60, 131-138.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer